Partial-onset Seizures
📧 Sign up to get email alerts when something new happens for Partial-onset Seizures.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-06-08Clinical Trial Update: A Study of the Efficacy and Safety of Topiramate in the Treatment of Patients With Difficult to Control Epilepsy [Phase 2]
The Phase 2 study of Topiramate in patients with difficult-to-control epilepsy has completed, reporting on its efficacy and safety.
-
FDA approval · 2011-04-26FDA Approved: PREGABALIN — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for pregabalin submitted by Mylan Pharmaceuticals Inc., updating the regulatory status of the produc…
-
CLINICAL_TRIALS trial_result · 2010-12-20Clinical Trial Update: Conversion to Monotherapy Study With Keppra XR for Partial Seizures [Phase 3]
Phase 3 trial evaluating conversion to Keppra XR monotherapy for partial seizures in epilepsy; results from the completed study have been po…
-
FDA approval · 2010-12-15FDA Approved: LEVETIRACETAM — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for levetiracetam from Sun Pharmaceutical Industries, Inc., updating the approval status for this ge…
-
FDA approval · 2010-12-14FDA Approved: LEVETIRACETAM — Original Application (Cranbury Pharmaceuticals, LLC)
FDA approves Cranbury Pharmaceuticals' original application for a generic levetiracetam, supporting its use for partial-onset seizures, myoc…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2010-11-15Clinical Trial Update: A Study of the Effectiveness and Safety of Topiramate Monotherapy in Patients With Recently Diagnosed Partial-Onset Seizure [Phase 3]
Phase 3 trial evaluating the effectiveness and safety of topiramate as monotherapy for recently diagnosed partial-onset seizures has complet…
-
FDA approval · 2010-10-22FDA Approved: OXCARBAZEPINE — Supplemental Application (Advagen Pharma Limited)
FDA approved a supplemental application for oxcarbazepine submitted by Advagen Pharma Limited.
-
CLINICAL_TRIALS trial_result · 2010-10-20Clinical Trial Update: Safety of Intravenous Lacosamide Dose Followed by Twice Daily Oral Lacosamide in Subjects With Partial-onset Seizures [Phase 3]
Phase 3 trial update reports safety findings for intravenous lacosamide followed by twice-daily oral lacosamide in adults with partial-onset…
-
FDA approval · 2010-10-08FDA Approved: LEVETIRACETAM — Original Application (NorthStar RxLLC)
FDA approved a generic version of levetiracetam under an Original Application for NorthStar RxLLC.
-
FDA approval · 2010-06-29FDA Approved: OXCARBAZEPINE — Supplemental Application (ANI Pharmaceuticals, Inc.)
The FDA approved a supplemental application for oxcarbazepine by ANI Pharmaceuticals, Inc., updating regulatory approvals for this product.
-
FDA approval · 2010-05-31FDA Approved: ZONISAMIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved Sun Pharmaceutical's supplemental application for Zonisamide (zonisamide), indicating an update to the approved product.
-
FDA approval · 2010-04-20FDA Approved: VIMPAT — Original Application (UCB, Inc.)
FDA approved VIMPAT (lacosamide) through its Original Application submitted by UCB, Inc.
-
FDA approval · 2010-02-26FDA Approved: ZONISAMIDE — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for zonisamide submitted by Aurobindo Pharma Limited. The approval confirms the changes requeste…
-
CLINICAL_TRIALS trial_result · 2010-01-13Clinical Trial Update: Long-Term, Follow-Up Study Of the Safety And Efficacy Of Levetiracetam In Children With Partial Onset Seizures [Phase 3]
Long-term follow-up study evaluating the safety and efficacy of levetiracetam in children with partial-onset seizures (Phase 3).
-
FDA approval · 2010-01-04FDA Approved: PREGABALIN — Original Application (Mylan Pharmaceuticals Inc.)
FDA approved the original application for pregabalin from Mylan Pharmaceuticals, confirming a generic version of the drug.
-
FDA approval · 2009-11-18FDA Approved: VIMPAT — Supplemental Application (UCB, Inc.)
The FDA approved a supplemental application for Vimpat (lacosamide) to expand its approved indications.
-
FDA approval · 2009-08-24FDA Approved: LEVETIRACETAM — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for LEVETIRACETAM by Sun Pharmaceutical Industries, Inc., updating labeling based on the submission.…
-
FDA approval · 2009-08-20FDA Approved: LEVETIRACETAM SOLUTION — Supplemental Application (Chartwell RX, LLC)
The FDA approved a supplemental application to add a levetiracetam solution dosage form (generic) under Chartwell RX, LLC.
-
FDA approval · 2009-01-15FDA Approved: LEVETIRACETAM — Original Application (BluePoint Laboratories)
FDA approved the original application for levetiracetam as a generic product from BluePoint Laboratories.
-
FDA approval · 2009-01-15FDA Approved: LEVETIRACETAM — Original Application (Dr. Reddy's Laboratories Limited)
FDA approved Dr. Reddy's Laboratories Limited's generic levetiracetam (Original Application), making a generic antiepileptic product availab…
-
FDA approval · 2008-10-28FDA Approved: VIMPAT — Original Application (UCB, Inc.)
FDA approved VIMPAT (lacosamide) under Original Application by UCB, Inc., marking the initial approval for the treatment of partial-onset se…
-
FDA approval · 2008-10-28FDA Approved: VIMPAT — Original Application (UCB, Inc.)
FDA approved VIMPAT (lacosamide) through its original NDA for adjunctive treatment of partial-onset seizures in adults and in pediatric pati…
-
FDA approval · 2007-12-11FDA Approved: OXCARBAZEPINE — Original Application (ANI Pharmaceuticals, Inc.)
The FDA approved ANI Pharmaceuticals' original application for oxcarbazepine, a generic anticonvulsant indicated for partial-onset seizures …
-
FDA approval · 2007-10-09FDA Approved: OXCARBAZEPINE — Original Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved the original ANDA for oxcarbazepine from Glenmark Pharmaceuticals.
-
FDA approval · 2007-09-12FDA Approved: KEPPRA — Supplemental Application (UCB, Inc.)
FDA approved a supplemental application for Keppra (levetiracetam) from UCB, Inc., expanding the product's approved use and/or labeling.